-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 ObuxU/m/OwAPfABARMKMkQlGaf85T1yFWIrx1MCLy3QbYNS4cr2wmVSh9YlFR5de
 le9rq0MlM7CX3Vu0gKtBRw==

<SEC-DOCUMENT>/in/edgar/work/0000950130-00-006354/0000950130-00-006354.txt : 20001129
<SEC-HEADER>0000950130-00-006354.hdr.sgml : 20001129
ACCESSION NUMBER:		0000950130-00-006354
CONFORMED SUBMISSION TYPE:	8-K/A
PUBLIC DOCUMENT COUNT:		2
CONFORMED PERIOD OF REPORT:	20001120
ITEM INFORMATION:		
FILED AS OF DATE:		20001128

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BECTON DICKINSON & CO
		CENTRAL INDEX KEY:			0000010795
		STANDARD INDUSTRIAL CLASSIFICATION:	 [3841
]		IRS NUMBER:				220760120
		STATE OF INCORPORATION:			NJ
		FISCAL YEAR END:			0930
</COMPANY-DATA>

		FILING VALUES:
			FORM TYPE:		8-K/A
			SEC ACT:		
			SEC FILE NUMBER:	001-04802
			FILM NUMBER:		778198
</FILING-VALUES>

			BUSINESS ADDRESS:	
				STREET 1:		ONE BECTON DR
				CITY:			FRANKLIN LAKES
				STATE:			NJ
				ZIP:			07417-1880
				BUSINESS PHONE:		2018476800
</BUSINESS-ADDRESS>

				MAIL ADDRESS:	
					STREET 1:		ONE BECTON DR
					CITY:			FRANKLIN LAKE
					STATE:			NJ
					ZIP:			07417
</MAIL-ADDRESS>
</FILER>
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K/A
<SEQUENCE>1
<FILENAME>0001.txt
<DESCRIPTION>AMENDMENT TO FORM 8-K
<TEXT>

<PAGE>




                      SECURITIES AND EXCHANGE COMMISSION
                            WASHINGTON, D.C. 20549


                                   FORM 8-K/A

                                CURRENT REPORT


                    Pursuant to Section 13 or 15(d) of the
                        Securities Exchange Act of 1934


Date of Report (Date of earliest event reported)  November 20, 2000
                                                  -----------------


                         BECTON, DICKINSON AND COMPANY
- --------------------------------------------------------------------------------
            (Exact name of registrant as specified in its charter)

           New Jersey                001-4802                   22-0760120
- --------------------------------------------------------------------------------
    (State or other juris-         (Commission             (IRS Employer Iden-
   diction of incorporation)       File Number)            tification Number)


   1 Becton Drive, Franklin Lakes, New Jersey                   07417-1880
- --------------------------------------------------------------------------------
    (Address of principal executive offices)                    (Zip Code)


Registrant's telephone number, including area code          (201) 847-6800
                                                            --------------

                                      N/A
- --------------------------------------------------------------------------------
        (Former name or former addresses if changed since last report.)




<PAGE>




Item 9.      Regulation FD Disclosure

             See the supplemental financial information attached hereto as
             Exhibit 99, which is incorporated herein by reference.

<PAGE>



                                  SIGNATURES


        Pursuant to the requirements of the Securities Exchange Act of 1934, the
registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.

                                           BECTON, DICKINSON AND COMPANY
                                                  (Registrant)



                                           By: /s/ Michelle L. Defazio
                                               -----------------------
                                                   Michelle L. Defazio
                                                    Assistant Secretary


Date: November 20, 2000

                                     - 2 -

<PAGE>



                              INDEX TO EXHIBITS
                              -----------------

   Exhibit
   Number              Description of Exhibits
   ------              -----------------------

    99                 Supplemental Financial Information




</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99
<SEQUENCE>2
<FILENAME>0002.txt
<DESCRIPTION>SUPPLEMENTAL FINANCIAL INFORMATION
<TEXT>

<PAGE>


                                      BD
                                    FY 2000
            Revenues by Business Segments and Major Product Groups

                                       Quarter 4                 Total Year
                                -----------------------    --------------------
                                       % Growth                   % Growth
                                -----------------------    --------------------
                                 Total     US     Int'l    Total   US     Int'l
                                -----------------------    --------------------
Medical
   Injection System              -0.7%    -7.5%    5.6%     5.8%   4.6%    7.0%
   Infusion Therapy Systems      -5.1%   -10.6%   -1.5%     2.1%  10.6%   -3.3%
   Consumer Health Care         -10.7%   -16.0%    2.6%    -1.5%  -7.4%    9.3%
   Pharmaceutical Systems        13.6%    39.6%    7.8%     7.1%  14.9%    5.5%
   Other                         -5.1%    -9.7%    0.1%    -2.9%  -2.6%   -3.2%
                                -----------------------    --------------------
                                 -3.4%   -10.0%    3.4%     2.2%   0.5%    3.7%

Preanalytical Solutions           2.2%     0.2%    4.7%     5.1%   4.4%    6.0%

Biosciences
   Flow Cytometry                35.1%    44.7%   24.4%    36.3%  57.4%   15.7%
   Microbiolgy                    2.2%     0.5%    4.5%     2.7%   3.0%    2.4%
   Labware                        0.5%    -3.3%    5.9%     6.2%   6.0%    6.4%
                                -----------------------    --------------------
                                 12.7%    13.5%   11.7%    13.4%  18.1%    7.5%
                                -----------------------    --------------------

   Total Company                  1.9%    -1.4%    5.8%     5.8%   6.6%    5.0%
                                =======================    ====================


<PAGE>


                                      BD
                                    FY 2000
            Revenues by Business Segments and Major Product Groups
                                ($ in Millions)

                                    Quarter 4                   Total Year
                              -----------------------    ----------------------
                                      Amount                      Amount
                              -----------------------    ----------------------
                              Total     US     Int'l      Total     US   Int'l
                              -----------------------    ----------------------
Medical
   Injection System            $153     $ 68     $ 84    $  609  $  295  $  314
   Infusion Therapy Systems      79       30       50       342     144     198
   Consumer Health Care         143       96       47       505     307     198
   Pharmaceutical Systems        66       15       51       255      48     207
   Other                         61       30       31       255     134     121
                              -----------------------    ----------------------
                                502      239      263     1,966     927   1,039

Preanalytical Solutions         131       71       59       535     292     243

Biosciences
   Flow Cytometry               113       64       49       407     232     175
   Microbiolgy                  137       78       59       568     332     236
   Labware                       37       21       16       143      81      62
                              -----------------------    ----------------------
                                287      163      124     1,118     644     473
                              -----------------------    ----------------------

   Total Company               $920     $474     $446    $3,618  $1,864  $1,755
                              =======================    ======================




</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
